Cambridge Investment Research Advisors
PSIL icon

Cambridge Investment Research Advisors’s AdvisorShares Psychedelics ETF PSIL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PSIL Stock Details PSIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,011
Closed -$59K – 3276
2021
Q4 		$59K Buy
+1,011
New +$80.9K ﹤0.01% 3087

Other funds holding PSIL

IWA
Intercontinental Wealth Advisors San Antonio, Texas $419M AUM 22.15% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Cambridge Investment Research Advisors's PSIL Position: Q1 2022 in Review

Cambridge Investment Research Advisors sold out of AdvisorShares Psychedelics ETF (PSIL) in Q1 2022, closing a stake of 1,011 shares — an estimated $59K sold.

Cambridge Investment Research Advisors first reported a position in PSIL in Q4 2021 and held it in 1 quarter. The position peaked at $59K in Q4 2021. 9 funds tracked by Wall St. Rank hold PSIL as of Q1 2022.

  • Cambridge Investment Research Advisors reported no remaining AdvisorShares Psychedelics ETF position as of Q1 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,011 AdvisorShares Psychedelics ETF shares in Q1 2022, an estimated $59K.
  • Cambridge Investment Research Advisors first reported a position in AdvisorShares Psychedelics ETF in Q4 2021 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's AdvisorShares Psychedelics ETF position peaked at $59K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held AdvisorShares Psychedelics ETF as of Q1 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.